ARCHIVE # 1: 1,457 HEADLINES from 8/2006 to 12/2004
Dr. Timothy L. Vollmer
Chairman, Division of Barrow Neurology

Director, Barrow NeuroImmunology Program

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
My Educational Video on MS and MS Trials
Produced by MD Health Channel
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT!
Visitors Since 03/2006!
Our 841 MySpace Friends
Join us..if you've been affected by MS
THIS COULD SAVE TOUR LIFE!
IF THERE IS A PROBLEM WITH ANY MS DRUG! READ THIS PLEASE: YOU NEED TO CLICK THE RED BUTTON BELOW & GET OUR FREE "MS News Alerts". WE SEND YOU BREAKING NEWS ON ALL MS DRUGS: Scroll down & read what we did last year...within 24 hours of the 1st death from the MS drug Tysabri!
IMPORTANT: We filmed the video below within hours of the 1st death from Tysabri and e-mailed it to everyone who clicked the Flashing Red Button above!...WATCH THE VIDEO...THEN CLICK THE FLASHING RED BUTTON ABOVE!
Timothy L. Vollmer M.D.
Director, Barrow NeuroImmunology Program
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center


BARROW NEUROLOGICAL INSTITUTE'S GRAND CANYON
RIM-RIM-HIKE

Organized by Dr. Spetzler

250 Photo-Slideshow


Click to view 1280 MS Walk photos!

"Join a trial at Barrow & receive all medication & study based procedures at no charge!"
Stan Swartz, CEO, The MD Health Channel

"WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below:

.

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes
Multiple Sclerosis Research
Barrow Neurological Institute

"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"

Chris Uithoven
President
National Multiple Sclerosis Society
Arizona Chapter


"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner
Program Director
National Multiple Sclerosis Society
Arizona Chapter

Previious Posts

MS NEWS ARCHIVES: by week
12.04  
01.05  
02.05  
03.05  
04.05  
05.05  
06.05  
07.05  
08.05  
09.05  
10.05  
11.05  
12.05  
01.06  
02.06  
03.06  
04.06  
05.06  
08.06  
09.06  
07.13  
04.14  

This page is powered by Blogger. Isn't yours?

December 05, 2005

 

STUDY: By Dr. Timothy Vollmer, Dr. Denise Campagnolo, Tuula Tyry from Barrow Neurological Institute and others...

"Changes in the ascertainment of MS"
















Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T.


A team of researchers including Dr. Timothy Vollmer, Dr. Denise Campagnolo, Tuula Tyry from Barrow Neurological Institute and RA Marrie, G Cutter and O Hadjimichael decided to test that assumption using the NARCOMS database, a voluntary MS registry based on self-reported information. They identified over 16,000 participants who met the study criteria (for example, who reside in the US, who had reported both onset and diagnosis dates, and whose onset began in 1980 or later, when MRI was starting to become more important in MS diagnosis). Analysis of the onset and diagnosis dates confirmed that those with onset in more recent years had a shorter delay before diagnosis than those with onset in earlier years. Analysis of disability data also revealed that those with onset in recent years had on average milder disability at diagnosis than those whose onset had occurred earlier.

STUDY CONCLUSION:
The delay from symptom onset to diagnosis is steadily decreasing in MS. An increasing proportion of patients with MS have mild disability at diagnosis after accounting for confounders. As the effectiveness of therapies is influenced by disease duration, this has implications for comparison of treatment effects in modern clinical trials to earlier study results."
MORE: Entrez PubMed